Q4 2023 Ironwood Pharmaceuticals Inc Earnings Call Transcript
Good day, and welcome to the Ironwood Pharmaceuticals fourth quarter and full-year 2023 investor update Call. (Operator Instructions). And finally, I would like to advise all participants that this call is being recorded. Thank you.
I'd now like to welcome Matt Roache, Director of Investor Relations, to begin the conference. Matt, over to you.
Thank you, Gavin. Good morning, and thanks for joining us for our fourth quarter and full-year 2023 investor update. Our press release issued this morning can be found on our website. Today's call and accompanying slides include forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is available on the current Safe Harbor statement slide as well as under the heading Risk Factors in our annual report on Form 10-K for the year ended December 31, 2022, and our quarterly report on Form 10-Q for the quarters ended June 30,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
